• A case of acanthosis nigricans-like mycosis fungoides
• A Case Report of Pityriasis Lichenoides-Like Mycosis Fungoides in Children: A Challenging Diagnosis
• A child with annular hypopigmented patches
• A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS
• Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas
• Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome
• An uncommon skin condition illustrates the need for caution when prescribing for friends
• Annular lichenoid dermatitis of youth: A case report and literature review
• Application of urine proteomics in the diagnosis and treatment effectiveness monitoring of early-stage Mycosis Fungoides
• Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model
• Association of a Proposed New Staging System for Folliculotropic Mycosis Fungoides With Prognostic Variables in a US Cohort
• Association of marital status with stage and survival in patients with mycosis fungoides: A population-based study
• Bexarotene: A Rare Cause of Misleading Thyroid Function Tests
• Case Report: Mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a <em>NFKB2</em> gene mutation
• Case Report: Mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a NFKB2 gene mutation
• CD20+ mycosis fungoides: a report of three cases and review of the literature
• Cell adhesion molecule 1 expression in mycosis fungoides versus parapsoriasis versus inflammatory dermatosis: an immunohistochemical comparative study
• Clinicopathological characteristics of adult T cell leukemia/lymphoma
• Clinicopathological correlation of acquired hypopigmentary disorders
• Comparative genomic hybridization identifies 17q11.2 approximately q12 duplication as an early event in cutaneous T-cell lymphomas
• Comparison of selective retinoic acid receptor- and retinoic X receptor-mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma
• Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy
• Confirmation of the biological significance of transthyretin as a biomarker for cutaneous T-cell lymphoma by its protein interaction partners
• Conjugal transformed mycosis fungoides: the unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphoma
• Cutaneous T-cell lymphoma in non-blood-related family members: report of an additional case
• Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC
• Cutaneous T-cell lymphoma: overview and nursing perspectives
• Cutavirus: A newly discovered parvovirus on the rise
• Detection of in-frame mutation by IS30-family insertion sequence in the phospholipid phosphatidylglycerol synthase gene (pgsA2) of high-level daptomycin-resistant Corynebacterium striatum
• Development of mycosis fungoides after bone marrow transplantation for chronic myeloid leukaemia: transmission from an allogeneic donor
• Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells
• Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database
• Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial
• Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma
• Estimation of the tissue and serum levels of IL-35 in Mycosis fungoides: a case-control study
• Evaluation of the Association Between Epstein-Barr Virus and Mycosis Fungoides
• Familial mycosis fungoides: model of genetic susceptibility
• Familial mycosis fungoides: report of 6 kindreds and a study of the HLA system
• Folliculin mutation-negative trichodiscomas in a patient with multiple endocine neoplasia type I syndrome
• Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes
• Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides
• High Expression of Intestinal Homing Receptor CD103 in Adult T-Cell Leukemia/Lymphoma, Similar to 2 Other CD8+ T-Cell Lymphomas
• HPyV6, HPyV7 and TSPyV DNA sequences detection in skin disease patients and healthy subjects
• Human herpesvirus 8 is not detectable in lesions of large plaque parapsoriasis, and in early-stage sporadic, familial, and juvenile cases of mycosis fungoides
• Human T-cell lymphotropic virus type 1 provirus and phylogenetic analysis in patients with mycosis fungoides and their family relatives
• Human T-lymphotropic virus type-1 (HTLV-1) in Israeli patients and their family relatives and its transmission to rats
• Hyper-IgE and Carcinoma in CADINS Disease
• Hypopigmented parapsoriasis en plaque, a new, overlooked member of the parapsoriasis family: a report of 34 patients and a 7-year experience
• Ichthyosis with superimposed mycosis fungoides, a rare case of generalized erythema with malaise
• Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries
• Imiquimod 5 percent cream and the treatment of cutaneous malignancy
• Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002
• Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy
• Itchy Skin: A Challenging Differential Diagnosis Between Mycosis Fungoides and Sezary Syndrome
• Juvenile-Onset Early-Stage Mycosis Fungoides-Associated Follicular Mucinosis: A Case Report
• Kaposi's varicelliform eruption in association with rosacea
• Loss of 5-Hydroxymethylcytosine Is an Epigenetic Biomarker in Cutaneous T-Cell Lymphoma
• Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sezary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project
• Molecular genetic analyses of human endogenous retroviral elements belonging to the HERV-P and HERV-R family in primary cutaneous T-cell lymphomas
• Monitoring malignant T-cell clones by direct TCR expression assay in patients with leukemic cutaneous T-cell lymphoma during extracorporeal photopheresis
• Mycosis fungoides and Sezary syndrome tumor cells express epidermal fatty acid-binding protein, whose expression decreases with loss of epidermotropism
• Mycosis fungoides as an ichthyosiform eruption
• Mycosis fungoides in childhood: description and study of two siblings
• Mycosis fungoides--a review of the management of 28 patients and of the recent literature
• NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
• Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis Fungoides
• Oral retinoids and rexinoids in cutaneous T-cell lymphomas
• Perspectives on and Quality of Life in Skin of Color Patients With Mycosis Fungoides/Sezary Syndrome: A Qualitative Analysis
• Polyclonal expansion of T cells with the TCR V beta type of the tumour cell in lesions of cutaneous T-cell lymphoma: evidence for possible superantigen involvement
• Poorer prognosis of African-American patients with mycosis fungoides: an analysis of the SEER dataset, 1988 to 2008
• Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
• Prognostic significance of Twist, ZEB1 and Slug in peripheral T-cell lymphomas
• Proteomic Profiling Change and Its Implies in the Early Mycosis Fungoides (MF) Using Isobaric Tags for Relative and Absolute Quantification (iTRAQ)
• Pruritic erythematous plaques
• Quality of life in patients with Mycosis Fungoides and Sezary Syndrome: a systematic review of the literature
• Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
• Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project
• Rediscovering alemtuzumab: current and emerging therapeutic roles
• Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis
• Response to: "Tumor stage mycosis fungoides in nonblood-related family members"
• SOHO State-of-the-Art Updates and Next Questions: A Modern Approach to the Systemic Treatment of Advanced CTCL
• Spatiotemporal changes and functional alterations of T-cell substates gene expression during the progression of mycosis fungoides
• Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sezary Syndrome: Efficacy, Safety, and Patient Selection
• Survival in non-Hodgkin's lymphoma by histology and family history
• Systemic therapy of cutaneous T-cell lymphoma (CTCL)
• The expression of MUM1 in cutaneous T-cell lymphoproliferative disorders
• The Free Sign in morphea and other sclerosing disorders: A clue to the presence of early sclerosis?
• The impact of gender, age, race/ethnicity, and stage on quality of life in a spectrum of cutaneous lymphomas
• The role of NLRP1 and NLRP3 inflammasomes in the etiopathogeneses of pityriasis lichenoides chronica and mycosis fungoides: an immunohistochemical study
• Therapeutic and prognostic significance of PARP-1 in advanced mycosis fungoides and Sezary syndrome
• Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas
• Total skin electron therapy as treatment for epitheliotropic lymphoma in a dog
• TOX acts an oncological role in mycosis fungoides
• TOX, TWIST1, STAT4, and SATB1 protein expressions in early-stage mycosis fungoides
• Transcription factor profiling shows new ways towards new treatment options of cutaneous T cell lymphomas
• Transferable vancomycin resistance in a community-associated MRSA lineage
• Tumor stage mycosis fungoides in nonblood-related family members
• Tumor Stage Mycosis Fungoides with Lymph Node Involvement
• Unveiling the hidden struggles: Exploring the profound impact of advanced stage cutaneous T-cell lymphoma on quality of life
• VALCHLOR (Mechlorethamine) 0.02% Gel